Inhaled racemic adrenalin versus saline in acute bronchiolitis, a multicenter randomized double-blind clinical trial Source: Annual Congress 2012 - New insights into respiratory infections in children Year: 2012
A randomised, placebo-controlled trial of inhaled mannitol in patients with bronchiectasis Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis Year: 2008
Randomized, double-blind, controlled trial of preventive inhalation of hypertonic saline in infants with CF (PRESIS) Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments Year: 2018
Antibiotic in non-purulent hospitalised-treated exacerbations of COPD: a randomised double-blind placebo-controlled trial Source: International Congress 2019 – Airway infection in COPD Year: 2019
A randomized crossover study of sputum induction by physiotherapy and hypertonic saline techniques in asthmatic children Source: International Congress 2017 – Diagnostic tools and comorbidities in paediatric asthma Year: 2017
Intravenous magnesium sulfate for acute wheezing in young children: a randomised double-blind trial Source: Eur Respir J, 51 (2) 1701579; 10.1183/13993003.01579-2017 Year: 2018
A prospective randomised double-blind placebo controlled trial of venlafaxine in patients with stable chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 32s Year: 2006
RCT Abstract - Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomized, double-blind, placebo-controlled, phase 3 trial Source: Virtual Congress 2021 – ALERT: Asthma in adult, in children and ILDs Year: 2021
Pulmonary vasodilator therapy in severe COPD: a double-blind, placebo-controlled trial Source: Eur Respir J 2007; 30: Suppl. 51, 525s Year: 2007
Acute effects of nasal high-flow during exercise in COPD patients after an exacerbation : a randomized controlled cross-over trial Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019
Airway hyperresponsiveness to mannitol as a predictor of treatment response to ciclesonide in patients with suspected asthma: A double-blind, randomised, placebo-controlled trial Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease Year: 2012
Methotrexate in treatment of severe difficult-to-treat asthma: randomized, double-blind, placebo-controlled study Source: Annual Congress 2007 - Towards controlling severe asthma Year: 2007
Nebulised hypertonic (7%) saline improves quality of life in a blinded randomised cross-over trial Source: Annual Congress 2010 - Management of airway disease Year: 2010
Budesonide versus prednisone in acute wheezing: randomized double-blinded controlled placebo study Source: Annual Congress 2008 - Treatment and outcome of childhood asthma: new perspectives Year: 2008
Sedation for bronchoscopy in children: a prospective randomized double-blinded trial Source: Virtual Congress 2021 – Posters in paediatric bronchology Year: 2021
Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial Source: Eur Respir J, 59 (1) 2100752; 10.1183/13993003.00752-2021 Year: 2022
The effect of bronchodilators in the exercise capacity and thoracoabdominal mechanics of subjects with bronchiectasis: a randomized crossover, double-blinded, placebo-controlled trial Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases Year: 2020
Acetazolamide administration following upper airway surgery for SDB. Preliminary results of a randomized, double-blind, placebo-controlled study Source: Eur Respir J 2005; 26: Suppl. 49, 201s Year: 2005
Azithromycin for the treatment of cough in idiopathic pulmonary fibrosis: A randomized controlled cross-over pilot trial. Source: Virtual Congress 2020 – Chronic cough: only symptom or disease? Year: 2020